Back | Next |
home / stock / asln / asln message board
Subject | By | Source | When |
---|---|---|---|
Price trading | ClayTrader | investorshub | 06/13/2023 9:21:00 PM |
MomentumIts now | ALERTS100%to10000%GAIN | investorshub | 06/09/2023 6:20:19 AM |
znewcar1: $ASLN 37% v735K c.5984 f69,744M H.65 ML.35 | znewcar1 | investorshangout | 01/04/2023 9:08:32 PM |
90.2 million cash on hand. | sick nam vet | investorshub | 03/25/2022 1:29:23 PM |
But $2.30 is nicer!!! | Termite7 | investorshub | 09/27/2021 2:58:18 PM |
$3.64 nice | wesley_ | investorshub | 07/09/2021 2:14:42 PM |
* * $ASLN Video Chart 03-01-2021 * * | ClayTrader | investorshub | 03/01/2021 10:01:42 PM |
znewcar1: ASLN 18% v52,1M c5.25 f37,9M preMH8.16 HOD6.75 then fell fast. | znewcar1 | investorshangout | 03/01/2021 9:28:52 PM |
$ASLC - $HRVSF - $UA - $SLV | Canna_Business | investorshub | 03/01/2021 2:18:12 PM |
$ASLN Pre-Market $7.62 +3.19 (+72.01%) | starbuxsux | investorshub | 03/01/2021 1:35:51 PM |
ASLAN Pharmaceuticals reports positive data from three dose | starbuxsux | investorshub | 03/01/2021 12:40:28 PM |
* * $ASLN Video Chart 02-25-2021 * * | ClayTrader | investorshub | 02/25/2021 11:12:27 PM |
znewcar1: ASLN 26% v12,4M c4.46 f37,9M H5.49 gap dipNgo to HOD then cylced around 4.4 | znewcar1 | investorshangout | 02/25/2021 9:12:29 PM |
AGREED | 2020trader | investorshub | 02/25/2021 8:49:31 PM |
$5.30 next leg up :) | wesley_ | investorshub | 02/25/2021 3:13:58 PM |
$4.70 nice | wesley_ | investorshub | 02/25/2021 2:42:16 PM |
Confidential treatment order ???? | jdheart101 | investorshub | 01/21/2021 9:17:45 PM |
Something going on here last night traded up | jdheart101 | investorshub | 01/05/2021 3:53:51 PM |
No selling , typical suck out with a | jdheart101 | investorshub | 12/16/2020 4:09:51 PM |
Started a position | jdheart101 | investorshub | 12/15/2020 5:32:59 PM |
News, Short Squeeze, Breakout and More Instantly...
ASLAN Pharmaceuticals Limited Company Name:
ASLN Stock Symbol:
NASDAQ Market:
New research collaboration will explore the differentiation of eblasakimab's mechanism of action versus biologic therapies for atopic dermatitis (AD), dupilumab and lebrikizumab . The findings will deepen understanding of the biology underlying the rece...
ASLAN management will present new data from the interim analysis of the TREK-DX study Register here to attend the webinar event on May 7, 2024 at...
ASLAN management will present new data from the interim analysis of the TREK-DX study Register here to attend the webinar event on May 7, 2024 at 8:00 AM ET SAN MATEO, Calif. and SINGAPORE, April 30, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), ...